March 7, 2018 07:09 AM ESTUpdated 08:53 AM
Financing
Startups
AI

SF tech start­up Atom­wise gets $45M for AI-pow­ered drug de­sign soft­ware

Brittany Meiling

A Sil­i­con Val­ley soft­ware com­pa­ny that’s us­ing ar­ti­fi­cial in­tel­li­gence to take the guess work out of struc­ture-based drug de­sign is trot­ting out a siz­able Se­ries …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Mi­crosoft-backed Enve­da rais­es $130M for drugs in I&I, obe­si­ty and oth­er ar­eas

As­traZeneca culls Phase 2 opi­oid use dis­or­der drug

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times